News of the WeekAIDS Research

IOM Panel Clears HIV Prevention Study

See allHide authors and affiliations

Science  15 Apr 2005:
Vol. 308, Issue 5720, pp. 334
DOI: 10.1126/science.308.5720.334b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

An Institute of Medicine (IOM) panel has found no major improprieties in the conduct of a key HIV trial in Uganda to prevent mother-to-child transmission in the late 1990s, essentially validating the use of a cheap, effective, and simple anti-HIV drug: nevirapine.